shortage semaglutide Out of Shortage, Into Controversy: The Fight Over GLP-1 Compounding Semaglutide Shortage Over? The FDA's

Hims & Hers failed to fully wind down its compounded semaglutide business and was sued by Novo Nordisk for patent infringement in February 2026 after it attempted to sell a compounded version of Novos newly approved Wegovy pill

it has been hypothesised to complement GLP-1 activity, though evidence in humans remains limited

DSIP should not be used in pregnancy or alongside sedative medications without medical supervision

First, they could easily miss the absolute contraindications we talked about earlier, like a personal or family history of MTC or MEN 2

If you're not familiar with the term GLP-1 medications, there's a decent chance you've heard them mentioned by their brand names

Pregnant individuals or those with existing health conditions should speak with a medical professional to determine whether IV therapy is appropriate for their situation